Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $107,224,205    

Indirect Value

   $145,808,454      
Total Shares   53,734,364      
Total Value   $253,032,660      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,030 Rapt Therapeutics, Inc. $22,803,513 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $82,104,662 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,030 Rapt Therapeutics, Inc. $22,803,513 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $82,104,662 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-26 4 B $4.85 $353,041 I/I 72,774 123,820 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-27 4 B $4.86 $373,638 I/I 76,877 200,697 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-11-03 4 B $4.99 $519,107 I/I 104,090 304,787 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-11-04 4 B $4.72 $165,320 I/I 35,058 339,845 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-11-21 4 B $5.00 $179,942 I/I 35,997 375,842 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-11-22 4 B $5.00 $21,646 I/I 4,330 380,172 2.17 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-12-12 4 B $4.98 $1,493 I/I 300 380,472 2.17 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-10 4 B $4.84 $484,519 I/I 100,070 480,542 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-11 4 B $4.76 $994,840 I/I 209,000 689,542 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-12 4 B $4.95 $26,603 I/I 5,378 694,920 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-19 4 B $5.00 $188,105 I/I 37,639 732,559 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-20 4 B $5.00 $2,498 I/I 500 733,059 2.17 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-23 4 B $5.00 $49,494 I/I 9,900 742,959 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-30 4 B $5.00 $37,707 I/I 7,542 750,501 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-31 4 B $5.00 $883,403 I/I 176,730 927,231 2.25 %
NGM Ngm Biopharmaceuticals In...   –       •       •   2023-11-15 4 B $0.71 $1,919 D/D 2,720 132,720 0.01 %
NGM Ngm Biopharmaceuticals In...   –       •       •   2023-11-15 4 B $0.71 $11,880 I/I 16,791 944,022 0.01 %
NGM Ngm Biopharmaceuticals In...   –       •       •   2023-11-16 4 B $0.62 $3,627 I/I 5,840 949,862 0.01 %
NGM Ngm Biopharmaceuticals In...   –       •       •   2023-11-16 4 B $0.62 $907 D/D 1,460 134,180 0.01 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2024-04-05 4 D $0.00 $0 I/I (21,874,413) 0 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2024-04-05 4 D $0.00 $0 D/D (134,180) 0 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2024-04-05 4 A $0.00 $0 I/I 1,000 1,000 0 -
NRIX Nurix Therapeutics, Inc. 10% Owner   –       –       •   2020-07-23 3 IO $0.00 $0 D/D 0 83,333 -
NRIX Nurix Therapeutics, Inc. Managing Partner   –       •       •   2020-07-28 4 A $0.00 $0 D/D 6,672,548 686,274 0 -
NRIX Nurix Therapeutics, Inc. General Partner   –       –       •   2021-05-05 4 D $0.00 $0 I/I (1,488,027) 0 0 -
  145  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us